Endoscopic sinus surgery was associated with improvement in self-reported olfactory function among patients with chronic rhinosinusitis with nasal polyps (CRSwNP), in which a longer CRSwNP disease course and higher blood eosinophilia were cited as risk factors linked with poor sense of smell recovery.
Endoscopic sinus surgery (ESS) was associated with an improvement in self-reported olfactory function among patients with chronic rhinosinusitis with nasal polyps (CRSwNP), although some risk factors may adversely affect sense of smell recovery. Results were published today in Frontiers in Surgery.
Cited by researchers as a predominant dysfunction present in CRSwNP, prior research shows diminished olfactory function has improved with ESS, especially in patients who did not achieve a clinically meaningful recovery after appropriate medical therapy. However, the improvement rate varies greatly: from 25% to 100%.
“Because olfactory examinations such as Sniffin sticks only represent patients’ olfactory level at the time the test is performed, an overall subjective judgment of olfaction by patients over time is also needed to reflect dynamic changes in olfaction as they impact patients’ quality of life,” said the study authors. “Identifying risk factors of olfactory dysfunction and postoperative olfactory recovery are essential for guiding physicians and patients regarding outcomes that can be achieved by ESS.”
Researchers conducted a prospective analysis of 56 patients with CRSwNP aged 24 to 63 years who failed medical treatment and completed functional ESS at the Department of Otolaryngology, Qilu Hospital, Shandong University, in China.
Participants reported their self-evaluated olfactory dysfunction score preoperatively and 1, 3, and 12 months after ESS. Preoperative clinical characteristics, CT scan (Lund–Mackay CT score [LMS]), and sinonasal endoscopy examination results (Lund-Kennedy [LK] endoscopy score) were collected prior to surgery.
Factors that predicted olfactory loss and affected the improvement of olfaction after ESS were also evaluated, including age, sex, duration of olfactory dysfunction, blood eosinophil counts, asthma, allergic rhinitis, prior surgery, LMS, LK endoscopy score, and peripheral distribution of CT opacification.
Of the study cohort, 8.9% (n = 5) presented with normosmia, 23.2% (n = 13) had mild impairment, 23.2% (n = 13) had moderate impairment, and 44.7% (n = 25) had complete anosmia. Olfactory improvement was observed 1 month after ESS.
Overall, 73.2% (n = 41) of patients experienced sustained recovery of subjective olfaction, in which the self-evaluated olfactory dysfunction score significantly improved from 2.04 to 0.64 (P < .001) after 12 months. Thirteen (23.2%) patients reported no change, and 2 (3.6%) patients suffered from deterioration.
In evaluating potential predictors of olfactory dysfunction, LMS (r = 0.593; P < .001) and LK endoscopy scores (r = 0.265; P < .05) were found to correlate with the preoperative olfactory dysfunction score. Multivariate logistic regression analysis also revealed that longer duration of olfactory dysfunction, blood eosinophilia, lower LMS, and peripheral distribution of CT opacification were risk factors that adversely affected the recovery of olfactory function (P < .05).
Speaking on limitations of the analysis, the researchers said that the subjective olfactory dysfunction ratings used were not validated by other studies. “Future studies on finding a standard subjective olfactory rating system may be needed,” they said.
Reference
Ye P, He S, Tang S, et al. Improvement of subjective olfactory dysfunction in chronic rhinosinusitis with nasal polyps after endoscopic sinus surgery. Front Surg. Published online June 15, 2022. doi:10.3389/fsurg.2022.870682
Insurers’ AI Denials of Postacute Care Face Senate Scrutiny
October 28th 2024Prior authorizations (PA) have been the subject of much scrutiny as of late through research demonstrating subsequent limited access to care in the aftermath of PA denials from use of artificial intelligence (AI) technologies.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Frameworks for Advancing Health Equity: Community Wellness Centers
September 27th 2024Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.
Listen
Infant Mortality Increases Across US Following Dobbs Decision
October 25th 2024The Dobbs decision was associated with a 7% absolute increase in overall infant mortality—equivalent to 247 excess deaths—and a 10% increase among infants with congenital anomalies, corresponding to 204 additional deaths.
Read More